| ●Editorial | Kurihara C | 350 | Full text | ||||
| ●Interviews and Reports at the World Medical Association’s General Assembly at Helsinki | |||||||
| World Medical Association’s Declaration of Helsinki, 2024 revision: Celebrating the 60th anniversary, at Helsinki |
Kurihara C，Matsuyama K， Baroutsou V （Trans. by Kurihara C，Matsuyama K） | W1-W27 | Full text | ||||
|
1. Introduction: the 2024 revision of the Declaration of Helsinki 2. Interviews with key experts 2.1 Dr. Alqodmani, the WMA Immediate Past President 2.2 Dr. Resneck, DoH revision Workgroup Chair 2.3 Dr. Mzukwa, South Africa 2.4 Prof. Tsai, Taiwan 2.5 Dr. Parsa-Parsi, Germany 2.6 Prof. Wiesing, Germany 2.7 Dr. Kloiber, Secretary General, WMA 2.8 Prof. Sprumont, WMA advisor and CIOMS 2.9 Prof. Greco, Previous WG member, CIOMS 2016 2.10 Dr. Snaedal, Previous Workgoup Chair for Taipei Declaration 2.11 Prof. Kim, Korean bioethicist 3. Conclusions and future perspectives: the Helsinki Statement | |||||||
| ●For the 2024 revision of the Declaration of Helsinki (Part 2): Webinar proceedings and statements from external stakeholders | |||||||
| ・Proceedings | |||||||
| The 2024 Declaration of Helsinki: Taking Forward Bioethics and Human Rights | 375-452 | Full text | |||||
| Co-organized by The Brazilian Society of Bioethics (SBB); International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP); Clinical Evaluation Inc.; The 129th Pharmaceutical Study Group Supported by The Japan Association for Bioethics (JAB) Cooperation: Japanese Association of Pharmaceutical Medicine (JAPhMed); Japanese Institute for Public Engagement (Ji4pe); Clinical Research Risk Management Study Group | |||||||
| ・Interview | |||||||
| Interview with Dr. Peter Lurie on the ethical controversies of placebo-controlled trials －As a part of the program of webinar on the 2024 Declaration of Helsinki: Taking forward Bioethics and Human Rights－ |
Lurie P （Interviewed by Kurihara C） |
453-62 | Full text | ||||
| ・Articles | |||||||
| Patient Public Declaration of Research Ethics (1st edition): Research ethics of the people, by the people, for the people －Expanding the impact of the 2024 revision of the Declaration of Helsinki ・Japanese |
Kurihara C，Saito Y， Kai H，et al. |
W28-W39 | Full text | ||||
| Noblesse oblige of the WMA in peril: Save its honor at the Diamond Anniversary | Saio T （Trans. by Saio T） |
W40-W45 | Full text | ||||
| Helsinki Statement from an Independent Stakeholders’ Group to Expand the Impact of the 2024 Revision of the WMA Declaration of Helsinki ・Japanese（W53-W59） ・Arabic（W60-W63） |
On behalf of the Helsinki Statement an ad hoc group of stakeholders |
W46-W52 | Full text | ||||
| ・Translations | |||||||
| Declaration of Helsinki: ethical norm in pursuit of common global goals ・Original publication in English |
Kurihara C，Kerpel-Fronius S， Becker S，et al. （Trans. by Kurihara C，Matsuyama K） |
499-508 | Abstract | ||||
| Vulnerability, social value and the equitable sharing of benefits from research: beyond the placebo and access debates ・Original publication in English |
Kurihara C，Greco D， Dhai A，et al. （Trans. by Kurihara C，Matsuyama K） |
509-22 | Abstract | ||||
| ●Instructions for authors［Japanese］＆［English］ | 523-31 | Full text | |||||
| ●Editor’s note | Mimura M | 533 | Full text | ||||